Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
2021 · The Lancet Oncology · 389 citations
https://doi.org/10.1016/s1470-2045(21)00336-3
Y
Yong Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
329
Papers
11.7K
Citations
53
h-index
174
i10-index
Yong Wang is an academic researcher from Qingdao University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Nanoparticle-Based Drug Delivery & MicroRNA in disease regulation. The author has an h-index of 53, co-authored 280 publications.
ORCID: 0000-0002-8349-7555Papers by this author
worksAltered microRNA expression in patients with non-obstructive azoospermia
2009 · Reproductive Biology and Endocrinology · 240 citations
https://doi.org/10.1186/1477-7827-7-13
Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC)
2020 · Biomedicine & Pharmacotherapy · 116 citations
https://doi.org/10.1016/j.biopha.2019.109561
Plant polyphenols alter a pathway of energy metabolism by inhibiting fecal Bacteroidetes and Firmicutes in vitro
2016 · Food & Function · 101 citations
https://doi.org/10.1039/c5fo01438g
miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC
2016 · Scientific Reports · 94 citations
https://doi.org/10.1038/srep23091
MiR–20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells
2017 · Cancer Cell International · 45 citations
https://doi.org/10.1186/s12935-017-0389-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat